Showing results (31-40 of 471) with videos related to
Sort By:
Pageof 48
Nature Reviews. Gastroenterology & Hepatology|February 11, 2015
NAFLD. Accurate quantification of hepatic fat--is it important?Leon A AdamsHepatology International|May 11, 2019
Correction to: End-points for drug treatment in NASHLeon A AdamsCurrent Opinion in Endocrinology, Diabetes, and Obesity|February 13, 2023
Cardiovascular disease in metabolic-associated fatty liver diseaseLeon A AdamsCurrent Hepatitis Reports|June 10, 2011
Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis BThierry Poynard, Yen Ngo, Mona Munteanu, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 15, 2013
Hepatic molecular effects of rosiglitazone in human non-alcoholic steatohepatitis suggest long-term pro-inflammatory damageMaud Lemoine, Lawrence Serfaty, Pascale Cervera, et al.Journal of Hepatology|December 4, 2003
Fibrogenic impact of high serum glucose in chronic hepatitis CVlad Ratziu, Mona Munteanu, Fréderic Charlotte, et al.Transplantation|October 10, 2018
Recommendations for Management and Treatment of Nonalcoholic SteatohepatitisVlad Ratziu, Marwan Ghabril, Manuel Romero-Gomez, et al.Journal of Gastrointestinal and Liver Diseases : JGLD|June 17, 2016
Real-life Perception and Practice Patterns of NAFLD/NASH in Romania: Results of a Survey Completed by 102 Board-certified GastroenterologistsSperanta Iacob, Carmen Ester, Mihaela Lita, et al.Hepatology (Baltimore, Md.)|August 21, 2018
Relationship Among Fatty Liver, Specific and Multiple-Site Atherosclerosis, and 10-Year Framingham ScoreRaluca Pais, Alban Redheuil, Philippe Cluzel, et al.Pageof 48